http://www.bionity.com/news/e/ The latest news about trends and developments in the biotech, pharma and life science industries en-us http://www.bionity.com/pictures/bionity/BionityCOM.gif http://www.bionity.com/?language=e Bionity.COM News http://www.bionity.com/news/e/82025/?WT.mc_id=ca0068 Affimed Therapeutics AG announced that a collaboration with Dr. Stefan Weiss at the Institute of Biochemistry of the Ludwig Maximilian University in Munich has strongly validated a target for cancer metastases amenable to the development of ... Bionity.COM News http://www.bionity.com/news/e/81986/?WT.mc_id=ca0068 Bone Medical Limited has obtained important positive data on blood levels of peptide from testing its oral parathyroid hormone (PTH) CaPTHymone(TM) osteoporosis product. These results are from a second clinical trial of CaPTHymone(TM) conducted at ... Bionity.COM News http://www.bionity.com/news/e/82007/?WT.mc_id=ca0068 Intercell AG and Iomai Corporation announced that they have entered into a definitive agreement pursuant to which Intercell will acquire Iomai for USD 6.60 per share representing a fully diluted equity value of approximately USD 189 million (EUR 122 ... Bionity.COM News http://www.bionity.com/news/e/82005/?WT.mc_id=ca0068 Selvita Sp. z o.o. announced the appointment of Dr. Nicolas D. Beuzen as its Chief Scientific Officer and Member of the Management Board. Dr. Beuzen will oversee all Selvita's drug research projects. After the first experience in 2002 as a Strategic ... Bionity.COM News http://www.bionity.com/news/e/81991/?WT.mc_id=ca0068 NicOx S.A. announced that Merck & Co., Inc. has initiated the first in a series of planned clinical studies, in mild to moderate hypertensive patients, under the companies' collaborative agreement to develop new nitric oxide-donating ... Bionity.COM News http://www.bionity.com/news/e/81962/?WT.mc_id=ca0068 In a study of the molecular mechanisms by which plants protect themselves from oxidation damage should they absorb too much sunlight during photosynthesis, a team of researchers has discovered a molecular "dimmer switch" that helps control the flow ... Bionity.COM News http://www.bionity.com/news/e/81961/?WT.mc_id=ca0068 Cytopia Limited announced that it has entered into an anti-cancer drug discovery and development collaboration with Cancer Therapeutics CRC Pty Ltd. This agreement leverages Cytopia's early stage drug discovery pipeline of kinase inhibitors, a class ... Bionity.COM News http://www.bionity.com/news/e/81960/?WT.mc_id=ca0068 KeyNeurotek Pharmaceuticals AG announced positive results of a Phase I study with its cannabinoid receptor-agonist KN38-7271. KN38-7271 is being developed for the treatment of patients suffering from acute neurodegenerative incidents like a stroke ... Bionity.COM News http://www.bionity.com/news/e/81957/?WT.mc_id=ca0068 Science, researchers at Five Prime Therapeutics, Inc. report the discovery of Interleukin34, a novel cytokine, as well as the identification of an IL-34 receptor."This work is a textbook example of how our platform enables us to make important new ... Bionity.COM News http://www.bionity.com/news/e/81964/?WT.mc_id=ca0068 Quest PharmaTech Inc. announced that it has signed a Technology Transfer Agreement with Peking Marvel Cleansing Supplies Co., Ltd., a China-based company, to sell its interest in the Bionex Technology. Peking Marvel is anticipated to be acquired by ... Bionity.COM News http://www.bionity.com/news/e/81893/?WT.mc_id=ca0068 Agilent Technologies Inc. announced the expansion of its nucleic acid active pharmaceutical ingredient (API) manufacturing facility in Boulder, Colo. Agilent's Nucleic Acids Solutions Division is adding large-scale nucleic acid synthesis, ... Bionity.COM News http://www.bionity.com/news/e/81894/?WT.mc_id=ca0068 CRELUX and ProQinase announced that they have entered into a joint agreement to supply customers with crystal-grade protein kinases and readily available kinase complex structures. Under the agreement, CRELUX and ProQinase will establish and ... Bionity.COM News http://www.bionity.com/news/e/81892/?WT.mc_id=ca0068 The EU Commission held a debate on the biotech crop approval process in Europe and sent out a disappointing signal when it agreed to send back three cultivation dossiers which had been positively assessed. Europe is already lagging behind worldwide ... Bionity.COM News http://www.bionity.com/news/e/81888/?WT.mc_id=ca0068 The odd-looking platypus is often cited as proof that God has a sense of humor. Now researchers at the Stanford University School of Medicine have turned to the strange animal to understand the genesis of an evolutionary tour de force that led to a ... Bionity.COM News http://www.bionity.com/news/e/81886/?WT.mc_id=ca0068 Microbix Biosystems Inc. announced that it intends to spin off its Urokinase assets into a new private company, Klarogen Biotherapeutics Inc., which would become the sole commercial-scale manufacturer and supplier of the clot-busting drug after a ... Bionity.COM News http://www.bionity.com/news/e/81825/?WT.mc_id=ca0068 Systems Biology is a young field. It has the potential to fundamentally change the life sciences and generate radically new insights for biomedical research as well as for industry and agriculture. Its overall aim is to better understand life ... Bionity.COM News http://www.bionity.com/news/e/81870/?WT.mc_id=ca0068 The secret to an unusual bacterium's massive size - it's the size of a grain of salt, or a million times bigger than E. coli bacteria, and big enough to see with the naked eye - may be found in its ability to copy its genome tens of thousands of ... Bionity.COM News http://www.bionity.com/news/e/81874/?WT.mc_id=ca0068 DIREVO Biotech AG announced that it has validated its "bestMab(TM)" platform through the generation of an optimized version of the anti-inflammatory antibody, Adalimumab (Humira®), with unprecedentedly strong binding properties. optiMIRA(TM) shows ... Bionity.COM News http://www.bionity.com/news/e/81868/?WT.mc_id=ca0068 LC Sciences announced that it has entered into a strategic marketing alliance with DNAVision to increase accessibility to its custom microRNA profiling service and enhance both its customer and technical service to researchers in Europe. "We are ... Bionity.COM News http://www.bionity.com/news/e/81871/?WT.mc_id=ca0068 Medgenics announced that it has appointed Dr. Ehud Shoshani, former CEO of Quintiles, Israel, as its Vice President of Clinical Affairs. Dr. Shoshani will manage the Company's Phase I/II clinical trials with EPODURE, its lead sustained-action ... © 2008, Chemie.DE Information Service GmbH.